COH Chicago — Zion, Illinois

COH Chicago is a clinical research site located in Zion, Illinois, United States 60099.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

COH Chicago has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma.

Sponsors: Generate Biomedicines.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Zion

Browse all research sites in Illinois · View every site in Zion

• Midwestern Regional Medical Center
• Research Site
• Cancer Treatment Centers of America
• City of Hope Chicago
• City of Hope at Chicago
• GSK Investigational Site
• Pfizer Investigational Site
• City of Hope® Cancer Center Chicago
• Midwestern Regional Medical Center dba City of Hope Chicago
• Cancer Treatment Centers of America at Midwestern Regional Medical Center
• City of Hope Chicago Cancer Center
• CTCA - Midwestern Regional Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for COH Chicago?

COH Chicago has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has COH Chicago conducted?

COH Chicago has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma.

Is COH Chicago accredited by Crixeo Clinical Trials?

COH Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about COH Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.